Progenics Pharmaceuticals, Inc. (PGNX) Posts Q1 EPS Loss of $0.69, Misses Consensus by 18c

May 10, 2011 8:19 AM

Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) reported Q1 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found